Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1
出版年份 2016 全文链接
标题
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 27, Issue 2, Pages 127-143
出版商
Informa UK Limited
发表日期
2016-10-24
DOI
10.1080/13543776.2017.1252753
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2
- (2016) Jason G. Kettle et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
- (2015) S J Thomas et al. BRITISH JOURNAL OF CANCER
- Development of Selective Covalent Janus Kinase 3 Inhibitors
- (2015) Li Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- (2014) Ho-June Lee et al. CANCER CELL
- The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
- (2014) Fiona Tan et al. CURRENT DRUG TARGETS
- Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634
- (2014) Christel J. Menet et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
- (2014) James D. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological targeting of the pseudokinase Her3
- (2014) Ting Xie et al. Nature Chemical Biology
- Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012
- (2013) Brian W Dymock et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Discovery of 1-Methyl-1H-imidazole Derivatives as Potent Jak2 Inhibitors
- (2013) Qibin Su et al. JOURNAL OF MEDICINAL CHEMISTRY
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology and significance of the JAK/STAT signalling pathways
- (2012) Hiu Kiu et al. GROWTH FACTORS
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779
- (2012) Benjamin J. Dugan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells
- (2011) Zhenjie Yin et al. ACTA HISTOCHEMICA
- BCR-ABL1—Negative Myeloproliferative Neoplasms: A Review of Molecular Biology, Diagnosis, and Treatment
- (2011) Erik Vakil et al. Clinical Lymphoma Myeloma & Leukemia
- Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway
- (2010) Stephanos Ioannidis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Janus Kinase 2 Inhibitors. Synthesis and Characterization of a Novel Polycyclic Azaindole
- (2009) Tiansheng Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of Stat3 in suppressing anti-tumor immunity
- (2008) Marcin Kortylewski et al. CURRENT OPINION IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started